Paper
0
First-in-class Transactivator-Free, Doxycycline-inducible IL-18-engineered CAR-T cells for relapsed/refractory B-cell lymphomas
Authors
Pedro Justicia-Lirio,María Tristán‐Manzano
Noelia Maldonado-Pérez,Carmen Barbero-Jiménez,Marina Cortijo-Gutiérrez,Kristina Pavlovic,Francisco Molina-Estévez,Pilar Muñoz,Ana Hinckley-Boned,Juan Rodríguez-Madoz,Felipe Prósper,Carmen Griñán‐Lisón,Saúl Navarro-Marchal,Julia Muñoz‐Ballester,Pedro Sierra,Concha Herrera,Juan Marchal,Francisco Martín,Juan Rodriguez‐Madoz
+17 authors
,Carla PaniselloPublished
Aug 15, 2024
Show more
Save
Tip0
TipSave